BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tantawy AAG, Adly AAM, Abdeen MSED, Salah NY. Cognitive decline and depressive symptoms: early non-motor presentations of parkinsonism among Egyptian Gaucher patients. Neurogenetics 2020;21:159-67. [DOI: 10.1007/s10048-020-00607-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang XL, Feng ST, Wang YT, Chen B, Wang ZZ, Chen NH, Zhang Y. Comparative efficacy and acceptability of drug treatments for Parkinson's disease with depression: A systematic review with network meta-analysis. Eur J Pharmacol 2022;:175070. [PMID: 35659968 DOI: 10.1016/j.ejphar.2022.175070] [Reference Citation Analysis]
2 Feng S, Wang X, Wang Y, Yuan Y, Li Z, Chen N, Wang Z, Zhang Y. Efficacy of Traditional Chinese Medicine Combined with Selective Serotonin Reuptake Inhibitors on the Treatment for Parkinson’s Disease with Depression: A Systematic Review and Meta-Analysis. Am J Chin Med 2021;49:627-43. [DOI: 10.1142/s0192415x21500282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
3 Grabowski GA, Antommaria AHM, Kolodny EH, Mistry PK. Gaucher disease: Basic and translational science needs for more complete therapy and management. Mol Genet Metab 2021;132:59-75. [PMID: 33419694 DOI: 10.1016/j.ymgme.2020.12.291] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
4 Ryan E, Amato D, MacKenzie JJ, Sidransky E, Lopez G. Parkinsonism in Patients with Neuronopathic (Type 3) Gaucher Disease: A Case Series. Mov Disord Clin Pract 2020;7:834-7. [PMID: 33043079 DOI: 10.1002/mdc3.13031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]